The UK drug regulator is investigating the risk of suicidal thoughts and of self-harm in patients using some weight loss and diabetes jabs.
The Medicines and Healthcare Products Regulatory Agency (MRHA) is conducting a safety review involving prescription-only medicines called GLP-1 receptor agonists.
